<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present study compared the potential neuroprotective effects of tanshinone (Tan) IIA monotherapy, tetramethylpyrazine (<z:chebi fb="5" ids="46324,9533">TMP</z:chebi>) monotherapy, and Tan IIA+<z:chebi fb="5" ids="46324,9533">TMP</z:chebi> combination therapy in adult rat subjected to cerebral ischemic injury using the permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model and in primary cortical neuron culture exposed to oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation (OGD) model </plain></SENT>
<SENT sid="1" pm="."><plain>Male Sprague Dawley rats (n=84) were randomly divided into sham-operated, MCAO, cmc-Na (<z:chebi fb="199" ids="26708">sodium</z:chebi> carboxymethyl cellulose), <z:chebi fb="5" ids="46324,9533">TMP</z:chebi>, Tan IIA+<z:chebi fb="5" ids="46324,9533">TMP</z:chebi>, and Tan IIA groups </plain></SENT>
<SENT sid="2" pm="."><plain>In agreement with the in vivo experiment, primary cortical neuron culture was prepared from one-day-old SD rats and grouped according to exposure: normoxia control (NC), OGD, <z:chebi fb="0" ids="28262">dimethyl sulfoxide</z:chebi>, <z:chebi fb="5" ids="46324,9533">TMP</z:chebi>, Tan IIA+<z:chebi fb="5" ids="46324,9533">TMP</z:chebi>, and Tan IIA groups </plain></SENT>
<SENT sid="3" pm="."><plain>The neurological deficits and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume were evaluated at 24h after the MCAO models </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> (malondialdehyde, <z:chebi fb="0" ids="16856">glutathione</z:chebi>, and <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase) and intracellular [Ca(2+)](i) concentration were measured through spectrophotometric analysis </plain></SENT>
<SENT sid="5" pm="."><plain>Neurocyte <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and viability were respectively evaluated through terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick end labeling and <z:chebi fb="0" ids="53233">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</z:chebi> assay, respectively </plain></SENT>
<SENT sid="6" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> factors (Bax, Bcl-2, caspase-3, and trmp-7) were analyzed using western blot and immunohistochemistry </plain></SENT>
<SENT sid="7" pm="."><plain>The results suggest that Tan IIA+<z:chebi fb="5" ids="46324,9533">TMP</z:chebi> combination therapy was more effective than <z:chebi fb="5" ids="46324,9533">TMP</z:chebi> monotherapy but not Tan IIA monotherapy </plain></SENT>
<SENT sid="8" pm="."><plain>Tan IIA monotherapy is more effective than <z:chebi fb="5" ids="46324,9533">TMP</z:chebi> monotherapy in protecting the neuron against <z:mp ids='MP_0005039'>hypoxia</z:mp>/<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> both in vitro and in vivo </plain></SENT>
<SENT sid="9" pm="."><plain>Interestingly, Tan IIA significantly increased the phosphorylation of AKT in primary cortical neuronal culture exposed to OGD, which was abolished by PI3K inhibitor LY294002 </plain></SENT>
<SENT sid="10" pm="."><plain>The PI3K/AKT signaling pathway may be involved in the neuroprotective mechanism of Tan IIA on primary cortical neurons </plain></SENT>
</text></document>